Orthocell CEO & MD, Paul Anderson, recently joined Micahel Frazis on the Frazis Capital Podcast.
The discussion centers on the company’s innovative collagen-based medical devices for regenerative medicine, encompassing products for bone regeneration, nerve repair, and tendon repair, all of which have demonstrated clinical success and promising market potential. While detailing their strategic partnerships and regulatory approvals, Paul highlights their expansion plans, particularly in the U.S. market, while maintaining a strong commitment to Australian manufacturing operations.
Have a listen: